Race‐specific prostate cancer outcomes in a cohort of low and favorable‐intermediate risk patients who underwent external beam radiation therapy from 1990 to 2017
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4802
Abstract: Previous research exploring the role of race on prostate cancer (PCa) outcomes has demonstrated greater rates of disease progression and poorer overall survival for African American (AA) compared to Caucasian American (CA) men. The current… read more here.
Keywords: low favorable; prostate cancer; intermediate risk; race ... See more keywords
Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance
Sign Up to like & getrecommendations! Published in 2019 at "Prostate Cancer and Prostatic Diseases"
DOI: 10.1038/s41391-019-0167-9
Abstract: Background We aimed to validate Decipher to predict adverse pathology (AP) at radical prostatectomy (RP) in men with National Comprehensive Cancer Network (NCCN) favorable-intermediate risk (F-IR) prostate cancer (PCa), and to better select F-IR candidates… read more here.
Keywords: risk; candidates active; intermediate risk; favorable intermediate ... See more keywords
Magnetic resonance radiomics for prediction of extraprostatic extension in non-favorable intermediate- and high-risk prostate cancer patients
Sign Up to like & getrecommendations! Published in 2020 at "Acta Radiologica"
DOI: 10.1177/0284185120905066
Abstract: Background To investigate whether magnetic resonance (MR) radiomic features combined with machine learning may aid in predicting extraprostatic extension (EPE) in high- and non-favorable intermediate-risk patients with prostate cancer. Purpose To investigate the diagnostic performance… read more here.
Keywords: non favorable; risk; radiology; favorable intermediate ... See more keywords